| Code | Title | Fellow | Organisation | Abstract | Final Summary |
| PCL/22/01 | Preventing Unintended Pregnancy in the Post-COVID-19 Era. | Dr John Reynolds-Wright | University of Edinburgh | PCL/22/01 | Project Active |
| PCL/22/03 | The role of cancer associated fibroblast heterogeneity in determining metastatic patterns in pancreatic and oesophageal adenocarcinoma. | Dr Stephan Dreyer | University of Glasgow | PCL/22/03 | Project Active |
| PCL/22/05 | The relationship between the tumour phenotype, JAK/STAT signalling, systemic inflammation, body composition and survival in patients with operable colorectal cancer. | Dr Ross Dolan | University of Glasgow | PCL/22/05 | Project Active |
| PCL/22/07 | Defining the prevalence of adverse host characteristics and their influence on prehabilitation response. | Dr Katrina Knight | University of Glasgow | PCL/22/07 | Project Active |
| PCL/21/01 | Using and improving Scotland’s care home data: a mixed methods programme of data linkage research and consensus gathering | Dr Jeni Burton | University of Glasgow | PCL/21/01 | Project Active |
| PCL/21/03 | The role of NFκB signalling in immune checkpoint expression and myeloid cell function in colorectal cancer | Dr Norman Galbraith | University of Glasgow | PCL/21/03 | Project Active |
| PCL/21/05 | Cardiovascular risk in early onset hypogonadism. | Dr Angela Lucas-Herald | University of Glasgow | PCL/21/05 | Project Active |
| PCL/20/01 | Temporal dynamics of multimorbidity and medication use with mental illness and dementia: an investigation in NHS Scotland routinely collected data and the Lothian Birth Cohort 1936 | Dr Lucy Stirland | University of Edinburgh | PCL/20/01 | PCL/20/01 Research Project Briefing |
| PCL/20/02 | The Role of Apelin and Apelin Receptor as therapeutic targets in lung inflammation and injury | Dr Simon Biddie | University of Edinburgh | PCL/20/02 | Project Active |
| PCL/20/05 | Single-cell transcriptomic analysis of anaesthetic effects on neuronal and non-neuronal cell populations modulating CNS vulnerability | Dr Zoeb Jiwaji | University of Edinburgh | PCL/20/05 | PCL/20/05 Research Project Briefing |
| PCL/20/10 | Defining the bi-directional relationship between cancer and kidney disease | Dr Jennifer Lees | University of Glasgow | PCL/20/10 | PCL/20/10 Research Project Briefing |
| PCL/19/01 | Precision treatment and drug repurposing to reduce endometriosis-associated pain in women | Dr Lucy Whittaker | University of Edinburgh | PCL/19/01 | Project Active |
| PCL/18/03 | Non-invasively quantifying, understanding and reversing myocardial fibrosis in renal failure | Dr Elaine Rutherford | University of Glasgow | PCL/18/03 | PCL/18/03 Research Project Briefing |
| PCL/18/05 | Derivation of a hospital episode frailty index from electronic patient records: understanding the role of frailty in health outcomes for older hospital patients in Scotland | Dr Atul Anand | University of Edinburgh | PCL/18/05 | PCL/18/05 Research Project Briefing |
| PCL/18/06 | Manipulating the immune microenvironment in Malignant Pleural Mesothelioma | Dr Clare Rooney | University of Glasgow | PCL/18/06 | Project Active |
| PCL/17/01 | Circuit-level pathophysiology and amelioration of NMDAR-channelopathies in two new rat models | Dr Katie Marwick | University of Edinburgh | PCL/17/01 | Project Active |
| PCL/17/03 | Characterising the role of CXCR2 signalling in colorectal cancer metastasis | Dr Colin Steele | University of Glasgow | PCL/17/03 | PCL/17/03 Research project briefing |
| PCL/17/04 | Combined magnetic resonance coronary angiography and positron emission tomography in patients with coronary artery disease | Dr Michelle Williams | University of Edinburgh | PCL/17/04 | PCL/17/04 Research Project briefing |
| PCL/17/07 | Identifying Novel Opportunities for Translational Research, Precision Medicine and Drug Repurposing in Cardiovascular Disease Using Pharmacoepidemiology, Genetic Epidemiology and Bioinformatics | Dr Ify Mordi | University of Dundee | PCL/17/07 | Project Active |
| PCL/17/10 | Improving predictions of prognosis in Parkinson’s: moving from intensive small-scale studies to large and reliable routinely collected datasets | Dr Angus Macleod | University of Aberdeen | PCL/17/10 | PCL/17/10 Research Project briefing |